These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7594790)

  • 1. A case of oral lichen planus with chronic hepatitis C successfully treated by glycyrrhizin.
    Nagao Y; Sata M; Tanikawa K; Kameyama T
    Kansenshogaku Zasshi; 1995 Aug; 69(8):940-4. PubMed ID: 7594790
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of glycyrrhizin for oral lichen planus in patients with chronic HCV infection.
    Da Nagao Y; Sata M; Suzuki H; Tanikawa K; Itoh K; Kameyama T
    J Gastroenterol; 1996 Oct; 31(5):691-5. PubMed ID: 8887036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The pharmacokinetics of the glycyrrhizin and glycyrrhetic acid after intravenous administration of glycyrrhizin for the patients with chronic liver disease caused by type C hepatitis virus].
    Takahashi M; Nakano S; Takeda I; Kumada T; Sugiyama K; Osada T; Kiriyama S; Toyoda H; Shimada S; Samori T
    Nihon Shokakibyo Gakkai Zasshi; 1995 Dec; 92(12):1929-36. PubMed ID: 8558777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of interferon combined glycyrrhizin therapy in patients with interferon-resistant chronic hepatitis C].
    Okuno T; Arai K; Shindo M
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):1022-5. PubMed ID: 7563661
    [No Abstract]   [Full Text] [Related]  

  • 5. Eosinophilic peritonitis responding to treatment with glycyrrhizin.
    Takeda H; Ohta K; Niki H; Matsumoto Y; Tanaka K; Machimura H; Yagame M; Inoue W; Endoh M; Kaneshige H
    Tokai J Exp Clin Med; 1991 Oct; 16(3-4):183-6. PubMed ID: 1811351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration-route dependency of absorption of glycyrrhizin in rats: intraperitoneal administration dramatically enhanced bioavailability.
    Yamamura Y; Santa T; Kotaki H; Uchino K; Sawada Y; Iga T
    Biol Pharm Bull; 1995 Feb; 18(2):337-41. PubMed ID: 7742809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of non-A, non-B hepatitis with glycyrrhizin].
    Ohta W; Iwamura K
    Nihon Rinsho; 1988 Dec; 46(12):2681-8. PubMed ID: 3149342
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics of glycyrrhizin after intravenous administration to rats.
    Tsai TH; Liao JF; Shum AY; Chen CF
    J Pharm Sci; 1992 Sep; 81(9):961-3. PubMed ID: 1432649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of glycyrrhizin in children with liver dysfunction associated with cytomegalovirus infection.
    Numazaki K; Umetsu M; Chiba S
    Tohoku J Exp Med; 1994 Feb; 172(2):147-53. PubMed ID: 8073426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variable clinical course of lichen planus following hepatitis C cure with direct-acting antivirals: A case series and literature review.
    Barajas L; Steuer M; Amerson E
    J Am Acad Dermatol; 2021 Apr; 84(4):1142-1146. PubMed ID: 32649959
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypokalemia and sodium retention in patients with diabetes and chronic hepatitis receiving insulin and glycyrrhizin.
    Fujiwara Y; Kikkawa R; Nakata K; Kitamura E; Takama T; Shigeta Y
    Endocrinol Jpn; 1983 Apr; 30(2):243-9. PubMed ID: 6357769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and laboratory observation on the effect of glycyrrhizin in acute and chronic viral hepatitis.
    Su XS; Chen HM; Wang LH; Jiang CF; Liu JH; Zhao MQ; Ma XH; Zhao YC; Han DW
    J Tradit Chin Med; 1984 Jun; 4(2):127-32. PubMed ID: 6567725
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of steroidal vs non-steroidal agents in oral lichen planus: a randomised, open-label study.
    Singh AR; Rai A; Aftab M; Jain S; Singh M
    J Laryngol Otol; 2017 Jan; 131(1):69-76. PubMed ID: 27917729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Erosive buccal lichen planus: nine case reports].
    Sellami A; Ezzine Sebai N; Zeglaoui F; Kharfi M; Zghal M; Mokhtar I; Fazaa B; Kamoun Mohamed R
    Tunis Med; 2002 May; 80(5):266-9. PubMed ID: 12534030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of adenine-arabinosine with glycyrrhizin in treating chronic active hepatitis].
    Zhang ZH; Yang ZH
    Zhong Xi Yi Jie He Za Zhi; 1988 Mar; 8(3):150-1, 157, 132-3. PubMed ID: 3416396
    [No Abstract]   [Full Text] [Related]  

  • 16. A case of pseudoaldosteronism induced by glycyrrhizin.
    Kageyama Y
    Nihon Jinzo Gakkai Shi; 1992 Jan; 34(1):99-102. PubMed ID: 1593803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic profiles of glycyrrhizin in patients with chronic hepatitis.
    Tanaka N; Yamamura Y; Santa T; Kotaki H; Uchino K; Sawada Y; Aikawa T; Osuga T; Iga T
    Biopharm Drug Dispos; 1993 Oct; 14(7):609-14. PubMed ID: 8251615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of glycyrrhizin on cortisol metabolism in humans.
    Soma R; Ikeda M; Morise T; Miyamori I; Takeda R
    Endocr Regul; 1994 Mar; 28(1):31-4. PubMed ID: 7949011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long term efficacy of glycyrrhizin in chronic hepatitis C patients.
    Arase Y; Ikeda K; Murashima N; Chayama K; Tsubota A; Koida I; Suzuki Y; Saitoh S; Kobayashi M; Kumada H
    Cancer; 1997 Apr; 79(8):1494-500. PubMed ID: 9118029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness of interferon, glycyrrhizin combination therapy in patients with chronic hepatitis C].
    Abe Y; Ueda T; Kato T; Kohli Y
    Nihon Rinsho; 1994 Jul; 52(7):1817-22. PubMed ID: 7521424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.